AngioLab안지오랩
251280 · KONEX · ₩251280 · 안지오랩
₩2,185▼ ₩160 (6.82%)End-of-day · Oct 30, 2026 · End-of-day prices.
Filings
- Investor relations (IR) event기업설명회(IR)개최Oct 22, 2026Open on DART
Predicted impact: Low
- Exercise of Conversion Rights of Convertible Shares전환주식의전환청구권행사Sep 22, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 14, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 7, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 31, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 24, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Aug 12, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 12, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최결과Jun 16, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최May 11, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 26, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 26, 2026Open on DART
- Audit report submitted감사보고서제출Mar 18, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 18, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 11, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 9, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Jan 22, 2026Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 12, 2025Open on DART
- Investor relations (IR) event기업설명회(IR)개최결과Sep 10, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Sep 10, 2025Open on DART
- Other Material Management Matters (Voluntary Disclosure): Conversion of Convertible Preferred Shares into Common Shares기타주요경영사항(자율공시) (전환우선주의 보통주 전환)Jul 17, 2025Open on DART
- Investor relations (IR) event기업설명회(IR)개최결과Apr 23, 2025Open on DART
- Other Material Management Matters (Voluntary Disclosure): Conversion of Convertible Preferred Shares into Common Shares기타주요경영사항(자율공시) (전환우선주의 보통주 전환)Apr 8, 2025Open on DART
- Annual general meeting results정기주주총회결과Mar 27, 2025Open on DART
- Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Mar 20, 2025Open on DART
- Audit report submitted감사보고서제출Mar 18, 2025Open on DART
- Annual report (Dec 2024)사업보고서 (2024.12)Mar 18, 2025Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 12, 2025Open on DART
- Shareholders' meeting called주주총회소집결의Mar 7, 2025Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Mar 7, 2025Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Mar 7, 2025Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Mar 4, 2025Open on DART
- Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)Feb 25, 2025Open on DART
- Rights offering (paid-in capital increase) decision주요사항보고서(유상증자결정)Feb 11, 2025Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 13, 2024Open on DART
- Investor relations (IR) event기업설명회(IR)개최결과Nov 14, 2024Open on DART
- Clinical Trial Stage Entry/Completion (Voluntary Disclosure) (MFDS Approval of IND for Phase 3 Clinical Trial Plan of ALS-L1023, a Treatment for Wet Age-Related Macular Degeneration)임상시험단계진입ㆍ종료(자율공시) (습성황반변성 치료제 ALS-L1023의 임상 3상 시험계획 (IND)에 대한 식약처 승인)Sep 10, 2024Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 29, 2024Open on DART
- Investor relations (IR) event기업설명회(IR)개최결과Apr 22, 2024Open on DART
- Annual general meeting results정기주주총회결과Mar 28, 2024Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Mar 28, 2024Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Mar 27, 2024Open on DART
- Audit report submitted감사보고서제출Mar 20, 2024Open on DART
- Annual report (Dec 2023)사업보고서 (2023.12)Mar 20, 2024Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 13, 2024Open on DART
- Shareholders' meeting called주주총회소집결의Mar 8, 2024Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Feb 14, 2024Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Feb 14, 2024Open on DART
- [Amended] Other Material Matters (Voluntary Disclosure) (Conversion Request for Convertible Preferred Shares into Common Shares)[기재정정]기타주요경영사항(자율공시)(전환우선주의 보통주 전환청구)Jan 30, 2024Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Jan 15, 2024Open on DART
Titles in Korean until English translations are added.
Also known as: AngioLab / 안지오랩 / 251280 / KRX:251280
Source: KRX statistical information